Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism

Springer Science and Business Media LLC - Tập 36 - Trang 625-627 - 2004
C.G Musso1,2, R. Guelman3, F. Varela1, R. Pidoux1, C. Schreck1, G. RosaDiez1, L. Plantalech3, L. Algranati1
1Department of Nephrology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
2Department of Nephrology, Hospital Italiano, de Buenos Aires, Temperley, Argentina
3Department of Endocrinology, Hospital Italiano, de Buenos Aires, Buenos Aires, Argentina

Tài liệu tham khảo

R Bergner K Dill D Boerner M Uppenkamp (2002) ArticleTitleElimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study. Nephrol Dial Transplant 17 1281–1285 D Lee K Kurokawa (1991) Phosphorous metabolism physiology M Maxwell C Kleeman R Narins (Eds) Clinical disorders of fluid and electrolyte metabolism Panamericana Buenos Aires 224–228 F Llach (1996) Renal osteodystrophy C Jacobs C Kjellstrand K Koch J Winchester (Eds) Replacement of Renal Function by Diálisis Kluwer Academic Publisher Dordrecht 1203 Fernandez E. Cardiovascular role of phosphorous. www./uninet./edu/cin2003/conf/fernandez/fernandez.htlm. J Delmez M Kaye (2001) Bone disease J Daugirdas P Blake T Ing (Eds) Handbook of dialysis Lippincott Williams & Williams Philadelphia 530–545